KIMBER TAYLOR: Open Payments
NPI 1801668017 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,213 in 188 payments from 38 companies in 2025. Trend: 2023 $19 · 2024 $1,584 · 2025 $4,213
Food & beverage: $3,936Education: $277
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 53 | $519 |
| Merck Sharp & Dohme LLC | 15 | $358 |
| AstraZeneca Pharmaceuticals LP | 15 | $334 |
| Janssen Biotech, Inc. | 14 | $281 |
| Caris MPI, Inc. | 6 | $279 |
| Fennec Pharmaceuticals, Inc. | 1 | $207 |
| Karyopharm Therapeutics Inc. | 4 | $201 |
| SOBI, INC | 7 | $200 |
| Incyte Corporation | 5 | $192 |
| Exelixis Inc. | 3 | $175 |
Products named: Enhertu, KEYTRUDA, MI CANCER SEEK, Fyarro, XPOVIO, Doptelet, IMFINZI, VERZENIO.
Industry payments across CO — which companies pay providers there.
